BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9008220)

  • 21. The effects of neutrons in Hiroshima. Implications for the risk estimates.
    Kellerer AM
    C R Acad Sci III; 1999; 322(2-3):229-37. PubMed ID: 10196677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Monte Carlo code for a direct estimation of radiation risk.
    Biaggi M; Ballarini F; Ferrari A; Ottolenghi A; Pelliccioni M
    Phys Med; 2001; 17 Suppl 1():103-5. PubMed ID: 11770522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A new assessment of the data from Hiroshima and Nagasaki].
    Kellerer AM
    Strahlenschutz Forsch Prax; 1988; 30():63-91. PubMed ID: 3222810
    [No Abstract]   [Full Text] [Related]  

  • 24. Estimates of neutron relative biological effectiveness derived from the Japanese atomic bomb survivors.
    Little MP
    Int J Radiat Biol; 1997 Dec; 72(6):715-26. PubMed ID: 9416794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hiroshima-like neutrons from A-bomb replica: physical basis for their use in biological experiments.
    Straume T; McDonald JC; Pederson RA; Brenner DJ; Dobson RL
    Radiat Res; 1991 Nov; 128(2):133-42. PubMed ID: 1947010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Life shortening in mice exposed to fission neutrons and gamma rays II. Duration-of-life and long-term fractionated exposures.
    Thomson JF; Williamson FS; Grahn D; Ainsworth EJ
    Radiat Res; 1981 Jun; 86(3):573-9. PubMed ID: 7244130
    [No Abstract]   [Full Text] [Related]  

  • 27. Salivary gland tumors among atomic bomb survivors, 1950-1987.
    Saku T; Hayashi Y; Takahara O; Matsuura H; Tokunaga M; Tokunaga M; Tokuoka S; Soda M; Mabuchi K; Land CE
    Cancer; 1997 Apr; 79(8):1465-75. PubMed ID: 9118025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indications of the neutron effect contribution in the solid cancer data of the A-bomb survivors.
    Kellerer AM; Rühm W; Walsh L
    Health Phys; 2006 Jun; 90(6):554-64. PubMed ID: 16691103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation risks. Study casts doubt on Hiroshima data.
    Marshall E
    Science; 1992 Oct; 258(5081):394. PubMed ID: 1411533
    [No Abstract]   [Full Text] [Related]  

  • 30. Hiroshima, Nagasaki and the RERF.
    Morgan C
    Am J Pathol; 1980 Mar; 98(3):843-56. PubMed ID: 6987891
    [No Abstract]   [Full Text] [Related]  

  • 31. Corrections to the paper "Fitting the Armitage-Doll model to radiation-exposed cohorts and implications for population cancer risks.
    Little MP; Hawkins MM; Charles MW; Hildreth NG
    Radiat Res; 1994 Jan; 137(1):124-8. PubMed ID: 8265782
    [No Abstract]   [Full Text] [Related]  

  • 32. Comments on the somatic effects section of the BEIR III report.
    Rossi HH
    Radiat Res; 1980 Dec; 84(3):395-406. PubMed ID: 6893867
    [No Abstract]   [Full Text] [Related]  

  • 33. Life shortening in mice exposed to fission neutrons and gamma rays I. Single and short-term fractionated exposures.
    Thomson JF; Williamson FS; Grahn D; Ainsworth EJ
    Radiat Res; 1981 Jun; 86(3):559-72. PubMed ID: 7244129
    [No Abstract]   [Full Text] [Related]  

  • 34. Dose-response relationship of neutron and gamma rays to chromosomally aberrant cells among atomic bomb survivors in Hiroshima and Nagasaki.
    Otake M
    J Radiat Res; 1979 Dec; 20(4):307-21. PubMed ID: 536952
    [No Abstract]   [Full Text] [Related]  

  • 35. The effects of small doses of ionizing radiation. Fundamental biophysical characteristics.
    Rossi HH
    Radiat Res; 1977 Jul; 71(1):1-8. PubMed ID: 877234
    [No Abstract]   [Full Text] [Related]  

  • 36. Comments on "Direct biological evidence for a significant neutron dose to survivors of the Hiroshima atomic bomb" by D.J. Brenner (Radiat. Res. 145, 501-507, 1996).
    Schmid E; Bauchinger M
    Radiat Res; 1996 Oct; 146(4):479-82. PubMed ID: 8927721
    [No Abstract]   [Full Text] [Related]  

  • 37. Corrections in the atomic bomb data to examine low dose risk.
    Baker GS; Hoel DG
    Health Phys; 2003 Dec; 85(6):709-20. PubMed ID: 14626322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors.
    Goodman MT; Cologne JB; Moriwaki H; Vaeth M; Mabuchi K
    Prev Med; 1997; 26(1):144-53. PubMed ID: 9010910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Responsibility beyond 60 years.
    Bennett BG
    Science; 2005 Sep; 309(5741):1649. PubMed ID: 16150979
    [No Abstract]   [Full Text] [Related]  

  • 40. Experimental derivation of relative biological effectiveness of A-bomb neutrons in Hiroshima and Nagasaki and implications for risk assessment.
    Sasaki MS; Nomura T; Ejima Y; Utsumi H; Endo S; Saito I; Itoh T; Hoshi M
    Radiat Res; 2008 Jul; 170(1):101-17. PubMed ID: 18582156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.